Regression of Iris Neovascularization After Intravitreal Bevacizumab

• By Yusuke Oshima, MD, PhD
  Oshima Eye Clinic Group
• Uploaded on Mar 21, 2013.
• Last modified by Caroline Bozell on Mar 21, 2013.
• Reviewed by Caroline Bozell

Rating

Appears in

Miscellaneous

Condition/keywords

intravitreal bevacizumab, iris neovascularization

Photographer

Yusuke Takada, Osaka University Graduate School of Medicine

Imaging device

Photo slit lamp biomicroscope

Description

Remarkable regression of iris neovascularization one day after intravitreal bevacizumab.

Related files